vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['urothelial', '#thor', 'erdafitinib']
2. #thor: erdafitinib vs chemo in advanced urothelial cancers in fgfr3/2alt (mut/fusion) - os w/ erdafitinib 12.1 mos vs 7.8 mos (hr 0.64)
- orr favored erdafitinib arm 45.6% vs 11.5%, w/ 6.6% cr
- aes w/ #erdafitinib: hyperphos, diarrhea, stomatitis #asco23 4/9 
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE